Navigation Links
Blacks and East Asians Prone To Side Effects of Cardiovascular Drugs

A new study conducted to analyze the incidence of adverse drug reactions in cardiac patients has revealed that it is more common in blacks and those of an East Asian origin//, the results of which are published in the British Medical Journal.

The results of the present study highlight that difference in ethnicity may play a crucial role in determining the extent of harm of a specific treatment, instituted to an individual patient. This difference in drug reaction could be attributed to either genetic constitution of an individual or other cultural factors, in the opinion of Dr. Robin E. Ferner, senior author of the study.

Researchers at the City Hospital in Birmingham gathered data from 24 different studies to analyze the ethnic difference in adverse drug reactions of cardiovascular agents. With respect to ACE inhibitors, black ethnicity was found to increase the risk of developing angioedema, characterized by inflammation of the face, throat, tongue or lips by a margin of three times.

Furthermore, blacks were also at increased risk (50% high risk) of developing intracranial bleeding (bleeding in the brain) as a consequence of clot-busting therapy, than their non black counterparts.

The effect was also true for patients of an East Asian origin. More specifically, ACE inhibitor therapy was associated with a three fold increased risk of cough when compared to white patients.

At this juncture, clearly more studies are needed to accurately assess the risk of cardiovascular drugs and its impact on individuals of diverse ethnic origin.


'"/>




Page: 1

Related medicine news :

1. Blacks decline Lung cancer surgery
2. Fewer Blacks Undergo Lung Cancer Surgery
3. Home Remedies More Used By Blacks And Native Americans
4. Malfunction Of Key Growth Factor Increases Mortality Rate From Pulmonary Fibrosis In Blacks
5. U.S: Prize for the best hearing category (ethnic groups) goes to…. Non-Hispanic Blacks
6. Bladder Cancer Has Worse Outcomes In Blacks
7. US Experts Necessitated On An Action Plan To Curb AIDS In Blacks
8. Genes May Trigger Repeated Premature Birth In Blacks
9. Blacks Get Treatment on Par With Whites for Cardiovascular Disease
10. South Asians in Canada being wooed by chips now!
11. South Asians Have Increased Heart Disease Risk in The UK
Post Your Comments:
(Date:7/23/2008)... DALLAS, July 23 /PRNewswire-USNewswire/ -- The Am...tries for the Howard L. Lewis,Achievement Award, t...nce,reporting., The award was established in 2000...f science, health and medical journalists who have...fight against heart disease and,stroke. This caree...
(Date:7/23/2008)... ALEXANDRIA, Va., July 23 /PRNewswire-USNewswire/ ...n be found in assisted living communities,accordin...ecial Committee,on Aging., "Assisted living is a ...nce and the opportunity for seniors to live enrich... Richard Grimes, the President and CEO,of the Assi...
(Date:7/23/2008)...- Conference Call Scheduled Tuesday, August 5, 200...RNewswire-FirstCall/ -- Almost Family, Inc.,(Nasda...alth nursing,services, announced today that it wil... June 30, 2008 on Tuesday, August 5, 2008, before ... results will begin at 11:00 a.m. ET on,August 5, ...
(Date:7/23/2008)... - Ann Arbor, Michigan Takes Top Honors as the #1 ...ON, July 23 /PRNewswire-USNewswire/ -- AARP The Ma... the world,s largest-circulation,magazine with mor... ten,healthiest cities to live and retire in with ..., NM, and Fargo, ND taking the top five rankings.,...
Breaking Medicine News(10 mins):Health News:ASSISTED LIVING: The Model for Person-Centered Long Term Care 2Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 3Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 4Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 5
...ndia may have escaped from the Bird Flu epidemic t...ly. It is known that migratory birds are carrying ...-headed geese’ usually migrate to India in winter ...rus strain H5N1 that can kill human beings. So far...
...ietic-cell transplantation with the use of conditi...chemotherapy, or both to decrease early toxic effe.../ transplantation to patients older than 50 years ...owever, acute graft-versus-host disease (GVHD) rem...
...n ingredient of turmeric that gives curry its must...curcuma longa plant, curcumin is a member of the g...al medicine, it is widely prescribed in Indian med...ders, rheumatism, diabetic wounds, runny nose, cou...
...ciation (IOA) and UNICEF would collaborate on spre...tection of HIV virus. The collaboration would help...f HIV infection//. The program would enhance natio...’s and young people are more attracted towards spo...
Other Medicine News:Health News:Protective regimen for acute Graft-versus-host disease 2Health News:Curcumin found to halt spread of breast cancer in mice 2Health News:Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness 2
(Date:7/21/2008)...ata from five 2008 conferences, GAITHERSBURG, Md....rivately held company developing gene therapies fo... on the VRX496 Phase I and Phase II,clinical trial...ity. VRX496,is an investigational gene therapy for... place on Thursday, July 24, 2008 at 11 a.m. EDT. ...
(Date:7/21/2008)... a Must for Clinical Trials Management, WASHINGTO...ion of,Academic Health Centers (AAHC) today launch...signed to assist academic health center leaders,r...ers in establishing,strengthening, and improving ... enterprise, particularly to manage and support co...
(Date:7/21/2008)...d limited launch in Italy continue, FRANKLIN, Mas...Inc.,(Amex: PLC ) announced today that it will de...its RenalGuard(TM) System in the prevention of,Con...nues to support the,investigator-sponsored clinica... limited market launch of RenalGuard in Europe, wh...
(Date:7/21/2008)...- Alfacell Corporation,(Nas...d in Molecular Cancer,Therapeutics (2008; 7(7):187...rnase) and the thiazolidinedione antidiabetic drug...s with increased expression of,PI3K-dependent Fra-...t of NIH-funded in vitro research conducted at,the...
Breaking Medicine Technology:VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5New AAHC Toolkit Available to Optimize Clinical Research Administration 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 3PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 4PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 5Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines 2Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo 28TM 29 to Reduce Pain Associated With Needle Insertion Procedures in Adul 3808 1Anesiva Announces Submission of Supplemental New Drug Application for Zingo 28TM 29 to Reduce Pain Associated With Needle Insertion Procedures in Adul 3808 2Anesiva Announces Submission of Supplemental New Drug Application for Zingo 28TM 29 to Reduce Pain Associated With Needle Insertion Procedures in Adul 3808 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo 28TM 29 to Reduce Pain Associated With Needle Insertion Procedures in Adul 3808 4Wyeth to Invest 24280 Million to Build State of the Art Nutritional Manufacturing Facility in China 13848 1Wyeth to Invest 24280 Million to Build State of the Art Nutritional Manufacturing Facility in China 13848 2Wyeth to Invest 24280 Million to Build State of the Art Nutritional Manufacturing Facility in China 13848 3Laborie Medical Technologies Receives FDA Pre Market Clearance for TETRA 28TM 29 NIRS Accessory for the US Market 13846 1Laborie Medical Technologies Receives FDA Pre Market Clearance for TETRA 28TM 29 NIRS Accessory for the US Market 13846 2Therap Services Welcomes Anna Keith to the US Customer Support Team 13843 1Therap Services Welcomes Anna Keith to the US Customer Support Team 13843 2
..., April 26, 2007,/PRNewswire-FirstCall/ - Angiotec...aceutical and medical device company, announced th...al examining the,Vascular Wrap(TM) Paclitaxel-Elut...oday at a scientific forum in Europe. The,two-year...cular,Wrap(TM) for use in arterial bypass surgery ...
...7 /PRNewswire-FirstCall/ --,Australian drug develo...liminary results from its randomised Phase II clin...cancer, where,Alchemia,s drug HyCAMP(TM) was compa...erstone drug for the treatment of colorectal,cance...y stage of,the analysis in accordance with the ASX...
Other Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 2Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 3Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 4Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 5Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 6Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 7
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. The set consists of an endobronchial blocker catheter and an Arndt Multiport Airway Adapte
The Pedia-Trake® is designed to reduce the possibility of over penetration., ,Pedia-Trake® is used to establish an emergency airway in pediatric patients more than one year old.
...yrotomy device, you can establish an airway (up to...cothyrotomy kit is used for fast and safe emergenc...a 4.5, 6.0 and a 7.2 mm I.D. airway within seconds...te ventilation. A suction catheter can be introduc...
...o establish emergency airway access through the cr...ludes a 12 gauge x 3" Angiocath I.V. catheter, whi...ock to ventilate. Designed to be used with the lit.... Similar to the Cook Emergency Cricothyrotomy Kit...
Medicine Products: